share_log

LIXTE Biotechnology Holdings Publication Pre-Clinical Data In Cancer Discovery Regarding LB-100

LIXTE Biotechnology Holdings Publication Pre-Clinical Data In Cancer Discovery Regarding LB-100

LIXTE Biotechnology Holdings 发布有关 LB-100 的癌症发现临床前数据
Benzinga ·  03/27 08:37

LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS

LB-100 与 WEE1 抑制协同杀死癌细胞;除了目前的三项LIXTE临床试验外,这一发现还开辟了新的治疗策略

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发